Immediate tumor resection in patients with locally advanced gastroesophageal adenocarcinoma with nonresponse to chemotherapy after 4 weeks of treatment versus resection after completion of chemotherapy (OPTITREAT trial, DRKS00004668): study protocol for a randomized controlled pilot trial

BACKGROUND: Neoadjuvant chemotherapy is a standard of care for patients with adenocarcinoma of the esophagus and stomach in Europe, but still only 20–40 % respond to therapy and the critical issue; how to treat nonresponding patients is still unclear. So far, there is no randomized trial evaluating...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Pilot Feasibility Stud
Glavni autori: Blank, Susanne, Knebel, Phillip, Haag, Georg-Martin, Bruckner, Thomas, Klaiber, Ulla, Burian, Maria, Schaible, Anja, Sisic, Leila, Schmidt, Thomas, Diener, Markus K., Ott, Katja
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2016
Teme:
Study Protocol
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5153833/
https://ncbi.nlm.nih.gov/pubmed/27965838
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40814-016-0059-x
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items